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A number of types of effector cells express surface receptors that are specific 
for the Fc portion of IgG (Fc3,R).I When such cells encounter target cells that 
have been opsonized with IgG antibodies, they form conjugates with the target 
cells by binding the opsonizing antibody to their Fc3,R. Subsequently, the effector 
cells either lyse or phagocytose the targets, depending upon the cell types that 
form the conjugates (1-4).  In this paper, we demonstrate that conjugate forma- 
tion  and  lysis  can  also  be  induced  by  using  covalently  cross-linked  antibody 
heteroaggregates that contain both anti-Fc~/R antibodies and antibodies directed 
against a target cell determinant. When effector cells bind such heteroaggregates 
to their Fc3,R, they will then specifically bind and lyse target cells that have not 
been opsonized, but which express the appropriate antigen. 
The purpose of these studies is twofold. First, we wished to produce specific 
effector  cells  that  are  more  potent  lytic  agents  than  the  classical  antibody- 
dependent cell-mediated cytolysis (ADCC)  effector cell.  In vitro  studies (5-9) 
have demonstrated that ADCC is readily inhibited by either immtme complexes 
or  high  concentrations of monomeric IgG,  both  of which are  present  in  the 
physiological environment. In the past, several investigators (10-13) found that 
ADCC effector cells that have been incubated with IgG antibodies and washed 
retain small amounts of antibody on their surfaces and can iyse target cells that 
bear the appropriate antigens.  Such "armed"  effector cells, however, are  only 
weakly  lytic and  require  high  effector-to-target  ratios  to  mediate  lysis.  More 
recently (14),  we have found that a  number of procedures, collectively termed 
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"franking" (to distinguish them from arming),  lead to nearly irreversible binding 
of relatively large amounts of antibody to effector cells.  Franked effector cells 
specifically and  efficiently lyse target  cells that  have not been pretreated  with 
antibody, but which express the appropriate antigen. Moreover, ADCC mediated 
by franked effector cells is much less inhibitable by immune complexes than  is 
classical ADCC. Franked effectors have been produced from murine and human 
cells (14, 15) and have been shown to lyse both red cell and tumor targets. These 
results have been confirmed (16) and extended (17) in other laboratories.  The 
use of antibody heteroaggregates, described in this paper, provides a simpler and 
more efficient method of franking effector cells. 
The second purpose of this study is to examine the mechanism of ADCC. By 
using Fab and  F(ab')2 fragments  in  the heteroaggregates,  we have established 
that the normal Fc-Fc~,R interaction is not required for lysis. On the other hand, 
if conjugates are formed using heteroaggregates containing anti-major histocom- 
patibility complex (MHC) class I molecules instead of anti-Fc~,R, very little lysis 
is observed. These results suggest a role for Fc"rR in both the conjugate-forming 
and lytic steps of ADCC. 
Materials and Methods 
Materials.  RPMI 1640 was purchased from Gibco Laboratories (Grand Island,  NY), 
glutamine,  penicillin, and streptomycin were from the National Institutes of Health media 
unit,  and phosphate-buffered saline (PBS), pH 7.2, was from Biofluids (Rockville, MD). 
Fetal calf serum (Microbiological Associates, Walkersviile, MD) was heated to 56°C for 1 
h  before use.  Trinitrobenzenesulfonic acid (TNBS) and dimethyl  suberimidate (DMS) 
were obtained from Pierce Chemical Co. (Rockville, IL). Sodium [51Cr]chromate (1 mCi/ 
ml, in isotonic saline) and sodium [125i]iodide (17 Ci/mg in aqueous saline) were purchased 
from New England  Nuclear (Boston, MA). N-Succinimidyl-3-(2-pyridyldithiol) propionate 
(SPDP)  was  obtained  from  Pharmacia  Fine  Chemicals  (Piscataway,  N  J).  Fluorescein 
isothiocyanate (FITC) and substituted rhodamine isothiocyanate (XRITC) were purchased 
from Research Organics,  Inc. (Cleveland, OH). FACS (fluorescence-activated  cell sorter) 
medium is Hanks' balanced salt solution without phenol red (Biofluids), pH 7.2, containing 
2% bovine serum albumin (Miles Laboratories, Inc., Elkhart,  IN) and 0.2% sodium azide. 
The culture medium used in these experiments was RPMI 1640 containing  5-10% fetal 
calf serum, 0.03% glutamine,  100 U/ml penicillin, and 100 #g/ml streptomycin. 
Antibody.  Rabbit anti-2,4-dinitrophenyl  (DNP) antibodies were isolated from immune 
serum by affinity chromatography followed by gel filtration  as described previously (18). 
The F(ab')2 fragment was prepared by pepsin digestion at pH 4.3 (14) and it gave a single 
band of Mr 100,000 by sodium dodecyl sulfate-polyacrylamide  gel electrophoresis (SDS- 
PAGE). The rat anti-mouse Fc'yR monoclonal antibody (mAb) 2.4G2 (19) and the mouse 
anti-human  polymorphonuclear leukocyte (PMN)  Fc~,R mAb 3G8 (20) were grown as 
ascites in nude mice and isolated by gel filtration  and ion-exchange  chromatography as 
described (19, 20). The Fab of 2.4G2 was prepared by papain digestion  (19) and did not 
contain any intact antibody as judged by SDS-PAGE. Sepharose-linked  2.4G2 was kindly 
provided by Dr. Howard Dickler (Immunology Branch,  NCI). Cells producing 34-1-2, a 
mouse IgG2a mAb with specificity for H-2K  d and H-2D  d, were a kind gift from Dr. David 
Sachs (21). Ascites fluid from 34-1-2, produced in nude mice, was precipitated with 50% 
saturated ammonium sulfate,  redissolved  in water, and dialyzed against borate-buffered 
saline (BBS), pH 8.5. It was then fractionated on an UItrogel AcA 34 (LKB Instruments, 
Inc.,  Rockville, MD) column in BBS and protein eluting at the IgG position  was pooled 
and further purified by protein A-Sepharose affinity chromatography. Bound 34-I-2 was 
eluted with 2 M KSCN and dialyzed immediately  against  BBS. The F(ab')2 fragment of 
34-1-2 was prepared by digesting  the intact protein with  10% (wt/wt) pepsin/mAb for 4 1688  EFFECTOR  CELLS  PRODUCED  BY  HETEROAGGREGATED ANTIBODIES 
h at 37 °C in 0.15 M sodium acetate, pH 4.0. The sample was then neutralized and passed 
over a protein A-Sepharose column; the nonadherent protein was further purified by gel 
filtration over AcA 34, and was homogeneous by SDS-PAGE. 
Cross-linking of Antibodies.  Heteroaggregates of 2.4G2  or 3G8 and  rabbit anti-DNP 
IgG antibodies were prepared using SPDP according to the manufacturer's protocol. The 
detailed  procedure for one preparation  was as follows. Rabbit anti-DNP IgG antibodies 
(2  ml,  12  mg/ml)  and  2.4G2  (4.6  ml,  5.2  mg/ml)  were  each  dialyzed  against  0.1  M 
potassium phosphate, 0.1  M NaCI, pH 7.5 (coupling buffer), and incubated separately for 
2 h at room temperature  with eightfold molar excesses of SPDP (125 #1 of a  3.2-mg/ml 
solution of SPDP in ethanol was added to each sample). The 2.4G2 was redialyzed against 
coupling buffer and the anti-DNP was dialyzed against 0.1 M sodium acetate, 0.1 M NaCI, 
pH 4.5.  Dithiothreitol  was then added to the anti-DNP to a  final concentration of 0.02 
M.  After 30 min at room temperature,  the anti-DNP was passed through a  Pharmacia 
PD10 column equilibrated  with coupling buffer, and immediately added to the  2.4G2. 
After 4  h  incubation at room temperature,  1 mg of iodoacetamide was added and  the 
protein was eluted on a 2.6 x  90 cm Ultrogel AcA 22 column in BBS plus 0.02% sodium 
azide.  Polymerized  material  was  collected  in  two  fractions  and  concentrated  using  a 
Millipore CX-10 immersible membrane. Total yields from the column were 16 mg of the 
heavy  cross-linked  fraction,  13  mg  of the  lighter  cross-linked  fraction,  and  6  mg  of 
monomeric IgG. Heteroaggregates of 2.4G2 (or 2.4G2 Fab) and rabbit F(ab')~ anti-DNP 
were prepared  similarly, except that the  SPDP 2.4G2  was reduced at pH 4.5 and then 
incubated with unreduced anti-DNP at pH 7.5. 
Anti-DNP  F(ab')~  was cross-linked with  34-1-2  F(ab')2 using  DMS  in order  to avoid 
reduction of the F(ab')2 fragment into the monovalent F(ab') fragments. The two proteins 
were dialyzed against 0.2 M Tris, pH 8.5, and 4.3 mg of each was mixed and concentrated 
to 0.2 ml with a CX-10 immersible membrane.  An eightfold molar excess of DMS over 
total protein was added (20 ml of an 11.2-mg/ml DMS solution in water), and the protein 
was incubated for 3 h  at room temperature.  The protein was then fractionated on AcA 
22,  yielding 0.9  mg of the  heavy cross-linked  fraction,  1.8  mg of the  lower molecular 
weight cross-linked fraction, and 2.1  mg of non-cross-linked F(ab')2. 
Binding Studies.  Antibodies were radiolabeled with  ~25I by a  modified chloramine T 
method (22). The amount of radiolabeled antibody associated with cells was determined 
as described (23). 
Target Cells.  Chicken red blood cells (CRBC) were labeled with 5~Cr as described (14). 
Tumor cell targets,  EL4 (a C57BL mouse lymphoma line) and RDM4 (an AKR mouse 
leukemia  line)  were grown in tissue culture and  radiolabeled  by incubating 0.25  ml of 
cells (~2  ×  107 cells/ml) with 0.25  ml ~Cr for 60 rain at  37°C in a  5% COz incubator 
and washing twice. P815 (a DBA/2 mouse mastocytoma line) was grown in tissue culture 
and radiolabeled  with  ~25I-UdR  (Amersham Corp.,  Arlington Heights,  IL) as described 
(24). For TNP labeling, CRBC were incubated with 10 mM TNBS and tumor cell targets 
with 5 mM TNBS in PBS, pH 7.2, for 10 min at 37°C, and washed twice. Control cells 
were incubated with PBS only. TNP CRBC used as targets in classical ADCC experiments 
were  incubated  with  subagglutinating  dilutions  on  anti-DNP  antibodies  for  30  min  at 
37 o  C. After extensive washing, target cells were counted and resuspended to the desired 
concentration in culture medium. 
Effector Cells.  Cells from the P388D~  mouse macrophage line were grown in spinner 
culture (25), harvested, washed twice, and resuspended to a final concentration of 2-4 x 
107 cells/ml in culture medium containing the desired concentration (usually 10-20 t~g/ 
ml) of cross-linked antibody (franking)  or monomeric anti-DNP  IgG (arming).  Control 
cells were incubated  in culture  medium only. After incubation at  0°C for 30-45  min, 
cells were washed twice and resuspended to the desired concentration in culture medium. 
Resident  peritoneal  exudate  cells  (PEC)  were  taken  from  6-8-wk-old  C57BL/6  mice 
(Frederick Cancer Research Center, Frederick,  MD) of either sex, as described (26). To 
obtain  activated  cells,  ~I0  7  viable  bacilli  Calmette-Gu~rin  (BCG)  (TMC  1011  lot  10; 
Trudeau  Institute,  Saranac  Lake,  NY) were injected  intraperitoneally  per  mouse.  PEC 
were then harvested 10-35 d after injection, as described (26). Human PMN were isolated KARPOVSKY  ET  AL.  1689 
from heparinized blood from normal donors by the method of Bass et al. (27). Contami- 
nating erythrocytes were lysed with distilled  water,  and the cells were washed twice in 
Hanks'  balanced  salt  solution.  These  cells  were  ~95%  PMN  by differential  leukocyte 
counts. Both mouse PEC and human PMN were franked with cross-linked antibody as for 
the P388D~ cells, except that 3G8 x  anti-DNP heteroaggregates were used for franking 
the PMN. 
Inhibition Studies.  Immune complexes used in inhibition experiments  were prepared 
by mixing  equal  (wt/wt)  amounts  of the  mouse  myeloma protein  UPC  120  (28)  and 
affinity-purified rabbit anti-mouse IgG2b antibody (kindly supplied by Dr. Jeffrey Blue- 
stone, Immunology Branch, NCI). Effector cells were incubated with immune complexes 
for 30  min at  0°C before addition  of target cells.  In hapten inhibition  studies,  graded 
concentrations of DNP eaminocaproic acid were added to the target cells before they 
were mixed with the effectors. When immune complexes or hapten were used as inhibitors, 
they remained  in  the  medium  during the cytotoxic phase  of the experiment.  In other 
studies,  2.4G2 was incubated with effector cells for 30 min at 0°C before adding cross- 
linked antibody. The cells were washed before being used in the assay. 
Chromium  Release  Assay.  Cytotoxicity  was  measured  as  previously  described  (14). 
Briefly, various numbers of effector cells were added to l0 s CRBC target cells or 2 X 104 
tumor  target  cells  in  the  wells  of  U-bottomed  microtiter  plates.  In  classical  ADCC 
experiments involving tumor targets, anti-DNP antibodies (10 ~g/ml final concentration) 
were  also  added  to  the  wells.  The  total  volume  in  all  wells  was  200  ~!.  After  20  h 
incubation for CBRC or 4  h  incubation for tumor target cells at  37°C in  5%  CO2 and 
100% humidity, supernatants were harvested by using the Titertek wick harvesting system 
(Flow Laboratories, Inc., Rockville, MD) and were assayed for the amount of SlCr released. 
Maximum lysis was determined by incubating target cells with an equal volume of 2  M 
HCI. Spontaneous lysis was measured in the supernatants of cultures containing l0 s S~Cr- 
labeled  CRBC and  106 unlabeled  CRBC in assays involving CRBC targets,  or 2  X  104 
5~Cr-labeled  tumor  targets  in  medium  alone  in  assays  for  tumor  target  cytolysis. 
The  percent  iysis  was  determined  from the  formula:  percent  lysis  =  100  x  [net cpm 
(experimental  release -  spontaneous release)/net cpm (maximum release -  spontaneous 
release)]. 
Assay for Dual Specificity of Heteroaggregated Antibody.  The anti-DNP activity of 2.4G2 
x anti-DN P was assayed by hemagglutination of TN P-coated sheep red blood cells (SRBC). 
SRBC were  incubated  in  10  mM  TNBS for  10  min at  37°C and  washed  twice.  TNP 
SRBC (50 #1 of a  0.5%  suspension) were then added  to 75 t~l of serial dilutions of the 
cross-linked antibodies in microtiter plates.  The plates were incubated  20 h at 4°C and 
read visually for hemagglutination. To show that anti-DNP activity was linked with anti- 
Fc~,R activity, heteroaggregates (0.75 ml, 10 #g/ml) were repeatedly adsorbed on P388D~ 
cells (4 x  107 cells/adsorbtion) before the hemagglutination assay. To correct for nonspe- 
cific adsorbtion and dilution effects, a control adsorption containing P388D1 cells and a 
saturating concentration of free 2.4G2 was done in parallel with the test adsorbtion. 
Conjugate Formation Assay.  The method of Segal and Stephan~ (29) was used. Briefly, 
P388D~ cells were washed once with PBS and resuspended at ~10  cells/ml in 10 ml PBS. 
The solution was made  10 ~M in FITC by adding 100 ~1 ofa 1-mM solution of FITC in 
ethanol. After 10 min incubation at 37 °C, the cells were centrifuged and washed twice in 
culture medium.  CRBC were washed once in PBS and resuspended  at ~ 107 cells/ml in 
10 mi  PBS containing  10  mM TNBS.  Next,  100/~1  of 0.5  mM XRITC in ethanol  was 
added and the cells were incubated for 10 min at 37°C, pelleted, and washed twice with 
culture medium. Some cells were then incubated with subagglutinating dilutions of anti- 
DNP antibodies for 30 min at 37°C and washed twice with culture medium. Both P388D~ 
cells and CRBC were washed in FACS medium and resuspended at the desired cell density 
(usually at  2  x  10  7 cells/ml).  Equal volumes of FITC P388D1  cells and XRITC CRBC 
were then mixed and maintained in suspension by rotation (5 rotation/min) in a 4°C cold 
room for 2 h. Aliquots were removed, diluted to ~10 B  cells/ml, and analyzed for conjugate 
formation using a  FACS II dual-laser cell sorter (B-D FACS Systems, Becton, Dickinson, 
& Co.,  Sunnyvale,  CA).  The cytometer sequentially  analyzes each  particle  for red and 1690  EFFECTOR  CELLS  PRODUCED  BY  HETEROAGGREGATED  ANTIBODIES 
green emission; free CRBC appear red only, free P388D~ cells green only, and conjugates 
both red and green.  The percentages of particles  detected as conjugates,  free P388D1 
cells,  or  free  CRBC  were determined  by integrating  the  appropriate  peaks  in  dual- 
parameter contour plots. 
Results 
Binding of Anti-Fc'yR × Anti-DNP F(ab')e to Effector and Target Cells.  Rabbit 
anti-DNP F(ab')~ antibodies were chemically cross-linked to 2.4G2, a monocional 
rat anti-mouse Fc'yR antibody, and the cross-linked material [termed anti-Fc3,R 
×  anti-DNP  F(ab')2]  was  isolated  by  gel  filtration.  To  demonstrate  that  the 
binding capacities were not destroyed by the cross-linking procedure, we labeled 
the anti-FeaR × anti-DNP F(ab')2 with 125I and measured its binding to P388D1 
cells (Fig.  1A) and to TNP CRBC (Fig. ]B). Fig.  1 shows that anti-Fc~,R ×  anti- 
DNP F(ab')2 binds saturably to P388D1 cells, and that binding is inhibitable by 
unlabeled anti-FeaR mAb but not by DNP hapten.  The anti-FcTR ×  anti-DNP 
F(ab')2 also binds to TNP CRBC, and binding is inhibitable by DNP hapten but 
not by unlabeled anti-FeaR mAb. The binding curve in Fig.  1 B does not reach 
a plateau in the concentration range tested, which is characteristic of the way in 
which our heterogeneous rabbit anti-DNP antibody preparations bind to TNP- 
treated target cells (30).  Fig.  1 demonstrates that anti-FcTR X anti-DNP F(ab')2 
binds to Fc'yR on P388DI cells and to TNP groups on TNP CRBC. To establish 
what proportion of the cross-linked molecules retained both functional activities, 
we adsorbed anti-Fc'yR X anti-DNP heteroaggregates on P388D~ cells. We then 
tested the material after adsorbtion for the presence of anti-DNP activity by its 
ability to agglutinate  TNP SRBC. The  results showed that  -70%  of anti-DNP 
activity  was  adsorbed  after  three  consecutive  incubations  with  P388D~  cells. 
Since anti-DNP  activity was still  being removed after  the  last adsorbtion,  it  is 
likely that  >70%  of the  molecules possessing anti-DNP  activity also bound to 
Fc7R. 
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FIGURE  l.  Binding of anti-Fc3,R ×  anti-DNP F(ab')~ antibody to P388DI cells and to TNP 
CRBC. The number of molecules (based on a molecular weight of 1.5 ×  10  s) of l~SI-labeled 
cross-linked antibody bound to the cells (ordinate) is plotted against the molar concentration 
of free antibody in which the cells were  incubated (abscissa). Binding of radiolabeled anti- 
Fc'yR x  anti-DNP F(ab')2 to P388DI cells (A) and to TNP CRBC (B). (A) Cross-linked antibody 
alone. (I--1) Cross-linked antibody in the presence of a  40-fold excess of unlabeled anti-FcyR 
mAb. (O) Cross-linked antibody in the presence of 10  -4 M DNP e-aminocaproate. KARPOVSKY  ET  AL.  1691 
Lysis of TNP CRBC by Franked P388DI Cells.  P388DI  cells were incubated 
with either anti-Fc'rR x anti-DNP or with anti-Fc~'R x anti-DNP F(ab')~, washed, 
and tested for their ability to lyse CRBC or TNP CRBC. P388D~ cells treated 
with either preparation  of hetero-cross-linked antibodies lysed TNP CRBC but 
not untreated  CRBC, and maximal  lysis was achieved when  P388D~ cells were 
treated  with a  5-10-#g/ml  solution of cross-linked  material  (Fig.  2).  Although 
10 mM TNBS was used in most experiments to modify CRBC, lysis could also 
be detected on  target  cells treated  with  as  little  as  0.5  mM  TNBS  (data  not 
shown).  Specificity  of lysis  was  further  demonstrated  by  showing  that  DNP 
hapten  inhibited  lysis in a  dose-dependent manner  (Table I).  To conform with 
previous publications (14,  15), we shall  refer to the attachment  of antibody to 
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FIGURE 2.  Lysis of TNP CRBC (O) and CRBC (n) by PB88Dl  franked with anti-Fc~,R x 
anti-DNP (A) and with anti-Fc~,R x  anti-DNP F(ab')~ (B) at a  10:1 effector-to-target  ratio. 
TABLE  I 
DNP Hapten Inhibition of TNP CRBC Lysis by Franked P388DI 
Cells 
Concentration of DNP 
hapten 
Percent inhibition of lysis 
P388Dl franked with: 
Anti-Fc~,R x  anti-  Anti-Fc3,R × anti- 
DNP*  DNP F(ab')~* 
M 
10 -1°  <0 e  5 
10  -s  <0 !  24 
10  -6  50  61 
10  -4  94  95 
* P388D~  cells, incubated with  10  #g/ml  anti-Fc~,R x  anti-DNP, were 
tested for lysis of TNP CRBC in a 20-h ~lCr release assay, at an effector- 
to-target ratio of 10:1.  Lysis in the absence of inhibitor was 34.5%. 
* Same as above except P388DI cells were incubated with 10 #g/ml anti- 
Fc'yR × anti-DNP F(ab')2. Lysis in the absence of inhibitor was 50.6%. 
t Lysis was greater in the presence of inhibitor than in its absence. 1692  EFFECTOR  CELLS  PRODUCED  BY  HETEROAGGREGATED  ANTIBODIES 
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FIGURE 3.  Lack  of requirement  of the Fc portion of IgG for cytolysis. Lysis of TNP CRBC 
by P388D] cells in a 20-h SlCr release assay. (r-l) P388D] cells franked with 25 ~g/ml anti- 
FcTR × anti-DNP tested against TNP CRBC. (O) P388D, cells franked with 25 #g/ml anti- 
Fcq,  R Fab × anti-DNP F(ab')2 tested against TNP CRBC. (A) Untreated  P388DI cells tested 
against TNP CRBC coated with anti-DNP antibody. (A) Untreated P388DI cells tested against 
TNP CRBC. 
Fc3'R on effector cells as "franking."  The  data  show that  franked  P388D]  cells 
will  specifically  lyse  TNP  CRBC,  and  that  the  Fc  portions  of the  anti-DNP 
antibodies  are not required  for lysis. These  data do not,  however,  rule out the 
possibility that  the Fc piece of the anti-Fc3,R  mAb is involved in  lysis. This was 
tested by cross-linking  the Fab fragment  of the anti-Fc3,R mAb with the F(ab')~ 
of anti-DNP.  Fig.  3  shows  that  P388D~  cells  franked  with  this  material  lysed 
TNP CRBC almost as effectively as P388Dl  cells franked with heteroaggregates 
of the intact antibodies.  Therefore,  lysis mediated by cells franked with antibody 
heteroaggregates  does  not  require  the  Fc  portions  to  be  present  on  either 
antibody. 
To  test  for  lysis  of  "innocent  bystander"  cells,  franked  P388D~  cells  were 
incubated with equal numbers of 5]Cr-labeled, unmodified CRBC, and unlabeled 
TNP CRBC. In this experiment (data not shown), specific lysis of the unmodified 
target cells was not observed, showing that lysis of innocent bystander cells does 
not occur in this system. 
The length of time that  P388D1 cells remain  cytolytic after franking  is shown 
in Table II. In this experiment, P388Dl cells were franked by the usual procedure 
at 0°C, and at time zero the cells were warmed to 37°C and periodically tested 
for  lysis against  TNP  CRBC.  Untreated  control  P388Dl  cells  were  tested  for 
lysis against  antibody-coated  target  cells.  The  results of Table  II  show that  the 
lytic activity of franked cells drops rapidly in the first 5 h of incubation,  and still 
further after an additional  11 h.  By contrast,  very little ADCC activity is lost by 
untreated  control cells. Because P388D] cells rapidly endocytose bound immune 
complexes (31),  it is remarkable  that detectable cytolytic activity remains  for as 
long as  16 h after franking. 
In  Table  III,  the  results  from  five  different  experiments  are  summarized, 
comparing  the  lysis  of antibody-coated  targets  (classical  ADCC)  with  lysis  of 
haptenated  targets by armed  or franked effector cells. These data show that,  in 
this system,  the franked  P388D]  cells are much  more potent  effectors than  the 
armed  cells,  and  that  lysis  mediated  by  the  franked  effectors  is  significantly KARPOVSKY  ET  AL. 
TABLE  II 
Percent Lysis after Incubation of Effectors in Medium* 
Time 
Percent specific  lysis 
ADCC with franked  Classical ADCO 
effectors* 
h 
0  66.8  36.0 
5  24.8  38.2 
16  5.7  25.9 
* At an effector-to-target ratio of 10:1 in a 20-h 5aCr release assay. 
* P388D~  cells were franked once with 50 #g/ml anti-Fc~,R x  anti-DNP 
at time zero and incubated in suspension at 37°C. At various times, the 
cells were washed twice and an aliquot was tested for cytotoxicity against 
TNP CRBC. 
! Same as above except that the effector cells were treated with medium 
only and were tested against TNP CRBC in the presence of 5 #g/ml of 
anti-DNP antibody. 
TABLE  III 
Lysis of Target Cells by P388D~ Cells* 
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Treatment of effector cells 
Percent lysis* of: 
Experiment  Antibody-  TNP 
coated TNP  CRBC  CRBC 
CRBC 
Incubated with medium only 
Incubated with  i anti-DNP antibody 
and washed (armed) 
1  12.2 (0.5)  -0.1  (4.1)  -0.5  (0.4) 
2  34.5 (1.0)  2.5 (0.5)  0.4 (0.4) 
3  13.8 (1.1)  3.0 (0.0)  2.9 (0.6) 
4  11.1 (1.4)  2.4(0.1)  -0.6(0.7) 
5  31.4 (5.7)  3.5 (0.6)  1.2 (0.3) 
1  16.8 (0.9)  7.5  (4.2)  -1.0  (0.4) 
2  40.3 (1.4)  12.6 (0.8)  1.0 (0.4) 
3  24.8 (2.8)  11.9 (0.9)  0.4 (0.4) 
4  13.5 (1.7)  5.9 (0.7)  -1.5 (0.5) 
5  16.9 (2.0)  5.7 (0.8)  1.5 (0.4) 
Franked  with  0  anti-Fc~,R  ×  anti-  1  50.4 (2.4)  44.5 (5.7)  -0.8 (0.4) 
DNP  2  46.3 (3.8)  34.8 (2.3)  1.5 (0.5) 
3  107.5 (2.8)  00.8 (1.6)  -0.1 (0.5) 
4  40.5 (5.5)  53.3 (2.8)  -0.9 (0.5) 
5  62.7 (3.6)  49.5 (2.1)  0.9 (0.2) 
* At effector-to-target ratios of 10:1. 
* Means of triplicate samples followed by standard errors in parenthesis. 
g P388D] cells were treated with 10-20/~g/ml ofanti-DNP antibody or anti-Fc~,R × anti-DNP. 
greater  than  that  observed  when  untreated  P388D]  cells  lyse  antibody-coated 
targets. 
Formation of Conjugates  Between TNP CRBC and Franked P388DI.  Conjugates 
between  franked  P388D1  cells  and  TNP  CRBC  were  detected  using  a  flow 
cytometric technique,  in which P388D1  cells and  TNP  CRBC  were  labeled with 
green- and  red-emitting  fluorophores,  respectively.  Cells were  mixed  at  4°C  to 1694  EFFECTOR  CELLS  PRODUCED  BY  HETEROAGGREGATED  ANTIBODIES 
allow conjugates to form but to prevent subsequent lysis,  and the suspensions 
were then analyzed using a dual-laser flow cytometer; free P388Dl  cells appear 
green only, free CRBC red only, and conjugates appear as single particles that 
are both red and green (e.g., Fig. 4D). Fig. 4 demonstrates that when untreated 
P388D1 cells were incubated with TNP CRBC, no conjugates formed (panel A). 
By contrast, when untreated P388D~ cells were incubated with antibody-coated 
TNP CRBC (panel B), or when franked P388D1 cells were incubated with TNP 
CRBC (panel D), stable conjugates were readily detected. Armed P388D~ cells 
(panel C) formed many fewer conjugates than did the franked P388D~ cells. In 
other experiments (data not shown), we found that DNP hapten inhibited the 
formation of conjugates between  franked  P388D~  cells and TNP CRBC,  and 
that pretreatment of P388D~ cells with anti-Fc3,R mAb prevented P388D~ cells 
from forming conjugates with antibody-coated TNP CRBC. 
Inhibition  of Lysis  and  Conjugate  Formation  by  Immune  Complexes.  Classical 
ADCC--that  is,  lysis  of antibody-coated target cells by Fc3,R-bearing effector 
cells is readily inhibited by immune complexes (5-9).  However, because of the 
extremely high affinity with which 2.4G2 binds to Fc3,R, we would expect lysis 
mediated by  franked  effectors  to be  much less sensitive to  immune complex 
inhibition.  We  therefore  tested  the  ability  of  immune  complexes  to  inhibit 
cytolysis and conjugate formation using franked, armed, or untreated effector 
cells. In Fig.  5A, graded concentrations of immune complexes were incubated 
with effectors and targets in a  20-h 51Cr release assay.  This figure shows that 
both the lysis of antibody-coated target cells by untreated P3.88Da  cells and the 
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FIGURE 4.  Extent of conjugate formation between P388Dl  cells and CRBC.  FITC-labeled 
P388DI cells were mixed with XRITC-labeled CRBC on a rotator in a 4°C cold room for 2 h 
and then samples were taken for cytometric analysis. Contours were drawn through points 
containing 10, 20, and 40 particles. A total of 5 x  104 particles was analyzed in each sample. 
(A) Untreated P388DI cells and TNP CRBC.  1.3% of the particles fall in the conjugate range. 
(B) Untreated P388D~ cells and TNP CRBC coated with anti-DNP antibody. Percent conju- 
gates,  18.8.  (C) Armed  P388DI  cells (incubated with anti-DNP antibody and washed) and 
TNP CRBC.  Percent conjugates, 3.2. (D) Franked P388D1 cells (anti-Fc3,R X anti-DNP) and 
TNP CRBC.  Percent conjugates, 15.5. 100 
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FIGURE 5.  Inhibition  of lysis  and  conjugate  formation  by  immune  complexes.  Immune 
complexes (mouse  IgG2b plus rabbit  anti-mouse  IgG2b) were first added  to effector cells, 
followed by addition of the target cells.  In both assays,  the immune complexes were present 
51  during the entire course of the assay.  (A) Inhibition of lysis in a  20-h  Cr release assay at a 
10:1  effector-to-target  ratio.  (B)  Inhibition  of conjugate  formation  as  measured  by  flow 
cytometry (see Fig. 4).  (O) Untreated P388D]  cells interacting with TNP CRBC coated with 
anti-DNP antibody.  In the absence of inhibitor, the percent lysis was  13.8 and the percent 
conjugates 24.5.  (I-7) Armed P388D~  cells interacting with TNP CRBC.  In the absence  of 
inhibitor, the percent lysis was  11.9.  Inhibition of conjugate formation could not be tested 
because too few conjugates (3.2%)  formed in the absence of inhibitor. (A) Franked P388D1 
cells (anti-Fc~,R  ×  anti-DNP) interacting with TNP CRBC. In the absence of inhibitor, the 
percent lysis was 90.8 and the percent conjugates was  15.5. 
lysis of TNP CRBC by P388D~ cells armed with anti-DNP antibodies are readily 
blocked by low concentrations of immune complexes. By contrast, lysis of TNP 
CRBC by P388Dl cells franked with anti-Fc~,R × anti-DNP is totally resistant to 
inhibition. As expected, the inhibition of conjugate formation followed the same 
pattern  (Fig.  5B); in  this experiment,  armed effector cells could not be tested 
for  inhibition  because  too  few conjugates  formed  in  the  absence  of immune 
complexes. 
Linkage of Target Cells to Fc'yR Is Necessary  for Lysis.  To test whether linkage 
to FcTR was required  for lysis  mediated by franked  effector cells, we formed 
conjugates in which the target cells were bound to MHC class I molecules on the 
effector  cells  rather  than  to  FeaR.  This  was  done  by  cross-linking  F(ab')2 
fragments  from  34-1-2,  a  monoclonal  antibody with  specificity for K a and  D a 
molecules, to F(ab')2 fragments from rabbit anti-DNP antibodies.  P388D1 cells 
(which are of the H-2  d hapiotype) were then incubated with this material  [anti- 
KdD  d F(ab')~ × anti-DNP F(ab')2], and their abilities to form conjugates and lyse 
TNP CRBC were compared with those of P388D~ cells franked with anti-FcyR 
x  anti-DNP.  P388D1 cells treated with anti-KdD  d F(ab')2 anti-DNP F(ab')2 were 
even more effective at forming conjugates than  were the P388DI cells franked 
with anti-Fc3,R  X anti-DNP  (Fig.  6A).  By contrast,  only the cells franked with 
anti-Fc'rR X anti-DNP mediated a high degree of lysis (Fig. 6B). Since a different 
cross-linking reagent (DMS) was used to form the anti-KdD  d F(ab')2 ×  anti-DNP 
F(ab')2  aggregates  than  was  used  to  make  anti-Fc3,R  ×  anti-DNP  (SPDP;  see 
Materials and Methods), it was possible that the difference in lytic activities could 
have arisen  from the difference in cross-linking  reagents.  However, we found 1696  EFFECTOR  CELLS  PRODUCED  BY  HETEROAGGREGATED  ANTIBODIES 
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FIGURE  6.  The requirement of linkage to Fc3,R for lysis of TNP CRBC  by P388D~ cells. 
P388Dj cells were treated with various concentrations of anti-Fc'rR × anti-DNP (I-1) or anti- 
KdD  d F(ab')2 × anti-DNP F(ab')2 (O) and analyzed for conjugate formation with TNP CRBC 
In  51  (A) or tested for cytotoxicity against TNP CRBC  "  a 20-h  Cr release assay (B) at a  10:1 
effector-to-target ratio.  In the absence of antibody, the percent conjugates was  1 and the 
percent lysis was 0.7. 
TABLE  IV 
Inhibition of Conjugate Formation and Lysis 
Inhibitor* 
P388D1 treated with:* 
Anti-KaD  d F(ab')2 x  Anti-Fcq,  R x 
anti-DNP F(ab')~  anti-DNP 
Percent conjugates with TNP CRBC 
None  26.8  15.5 
Anti-Fc3,R mAb  23.6  0.6 
Anti-KdD  n mAb  6.2  14.6 
Percent lysis of TNP CRBC* 
None  3.1 (1.1)  36.7 (0.9) 
Anti-Fc~'R mAb  0.7 (0.9)  0.5 (0.5) 
Anti-KdD  d mAb  3.8 (0.3)  29.9 (0.6) 
* P388D] cells were pretreated with 0.5 mg/ml antibody inhibitor or with 
medium for 30 rain at 0°C. Cross-linked beteroaggregates (25 tzg/ml) 
were then added and the ceils were incubated for an additional 30-rain 
period at 0°C and washed. 
* Means of triplicate samples followed by standard errors in parenthesis. 
At effector-to-target ratios of 10:1. 
that when the anti-Fc~,R ×  anti-DNP aggregates were formed using DMS instead 
of SPDP,  they were still active (data not shown). 
The  data in Table  IV show the results of experiments  in which  P388D]  cells 
were preincubated  with a  20-fold excesses of either anti-Fc3,R mAb or anti-KdD  d 
mAb  before  treatment  with  antibody  heteroaggregates.  As expected,  preincu- 
bation with free anti-Fc3,R mAb  prevented  conjugate formation and lysis medi- 
ated by P388D]  cells treated with anti-Fcq,  R  ×  anti-DNP, and preincubation with 
free anti-KaD  d mAb  inhibited conjugate formation by P388D]  cells treated with 
anti-KdD  d F(ab')2 ×  anti-DNP F(ab')9. When cells franked with anti-Fc3,R x  anti- 
DNP  were  pretreated  with  anti-KdD  d,  only  minor  effects  upon  conjugate  for- 
mation and lysis were observed, which demonstrates that the anti-class I antibody KARPOVSKY  ET  AL. 
TABLE  V 
Lysis of Target Cells by Franked Mouse and Human Effector Cells 
1697 
Percent lysis 
Effector-to-  Franked  Untreated* 
Experiment  Effector cells  Target cells  target ratio  effector  effector 
cells  cells 
1  Mouse resident PEC*  TNP CRBC  10  36.0  10.2 
2  Mouse BCG-activated PEC  g  TNP EL4  20  19.2  7.4 
3  Mouse BCG-activated PEC  !  TNP P815  15  5.5  -1.2 
4  Human PMN  I  TNP CRBC  10  83.7  5.6 
5  Human PMN**  TNP RDM4  75  12.8  -1.1 
* Incubated with medium only. 
* PEC from untreated mice franked with 50 #g/ml anti-Fc~,R (2.4G2) x  anti-DNP in a  20-h 5~Cr 
release assay. 
PEC from BCG-treated mice franked with 50 t~g]ml anti-Fc~,R (2.4G2) X anti-DNP in a 6-h 51Cr 
release assay. 
m  Same as above except that cytolysis was measured in a 6-h ~sI-UdR release assay. 
i PMN franked with 100 vg/ml anti-Fc~,R (3G8) X anti-DNP in a 20-h 51Cr release assay. 
** PMN franked with 1 mg/ml anti-Fc~,R (3G8) X anti-DNP in a 3.5-h 51Cr release assay. 
did  not  suppress  lysis.  In  an  attempt  to  trigger  lysis  in  nonlytic conjugates, 
P388D~  cells were first treated with anti-Fc~,R, then with anti-KdD  d F(ab')~  x 
anti-DNP  F(ab')2,  and  finally  with  TNP  CRBC.  Instead  of triggering  lysis, 
pretreatment of the effector cells with anti-Fc~,R inhibited the small amount of 
lysis (3.1%) mediated by the anti-KdD  d F(ab')2 × anti-DNP F(ab')2-treated effec- 
tors.  This  suggests  that  Fc~,R  were involved in  lysis  mediated by even  these 
effectors. Such an involvement could arise, for example, if the anti-KdD  d F(ab')2 
x  anti-DNP  F(ab')2  preparation  contained a  small  amount  of contaminating 
intact antibody. Further attempts to trigger lysis in nonlytic conjugates by adding 
immune complexes or  Sepharose-linked  2.4G2  to  preformed conjugates also 
failed (data not shown). Therefore, the cross-linking of Fc3,R in conjugates where 
the target cells are linked to class  I molecules instead of directly to Fc~R is not 
a lytic signal. 
Lysis of CRBC and Tumor Targets  by Franked Primary Effector  Cells.  The data 
presented  in  Table  V  demonstrate that  franked primary murine and  human 
effector cells can lyse CRBC and tumor targets. Franked resident PEC will lyse 
TNP CRBC (experiment 1) and, when activated with BCG, they will lyse tumor 
targets as well (experiments 2  and  3).  However, the extent of lysis of tumor 
targets  is  much  lower  than  for  CRBC,  and,  when  assayed  by  51Cr release 
(experiments  1  and  2),  PEC  mediate  a  relatively high  amount  of antibody- 
independent lysis. In another series of experiments, franked human PMN were 
tested for lysis against CRBC and tumor targets. To frank human PMN, the anti- 
Fc~R antibody 3G8  was cross-linked with anti-DNP antibodies. The 3G8 anti- 
body binds to  FcTR on human PMN and a  subset of lymphocytes, but not to 
Fc~R on monocytes (20). The avidity of 3G8 for human Fc3,R is reported to be 
substantially lower than that of 2.4G2  for the murine Fc3,R  (20).  The data of 
Table V show that franked human PMN will lyse both CRBC and tumor targets, 
although in order to detect lysis against tumor targets, high concentrations of 
franking antibody and high effectors-to-target ratios are required. 1698  EFFECTOR  CELLS  PRODUCED  BY  HETEROAGGREGATED  ANTIBODIES 
Discussion 
In classical ADCC, antibody-coated target cells are bound to Fc~,R on effector 
cells and  subsequently lysed.  Because we would expect ADCC  in  vivo  to  be 
inhibited by circulating IgG or immune complexes (32), we previously developed 
procedures by which antibody was artificially attached in vitro to the effector 
cell with high avidity, in order to override the normal in vivo suppression of 
ADCC. Such franked effectors were produced by incubating cells with relatively 
high concentrations (e.g., 1 mg/ml) of antibody in the presence of polyethylene 
glycol, and  then sedimenting them through  a  mixture of phthalate  oils  (14). 
While the chemical basis for franking was not clear, this procedure resulted in 
relatively large amounts of radiolabeled antibody becoming cell associated, and 
rendered the  cells  potent  effectors with  the  same specificity as  the antibody 
franked to them (14,  15).  Nevertheless, the earlier franking procedures were 
cumbersome and used large amounts of antibody, which was not all bound to 
FcTR  on  the  cell  surface,  and  some  of which  eluted  from  the  cells  during 
experimentation. 
In this paper,  we describe a  new, more specific method for franking mouse 
and human effector cells. In the mouse, the franking antibody is a heteroaggre- 
gate of the 2.4G2 anti-Fc3,R mAb covalently cross-linked to anti-DNP antibodies. 
This reagent binds to Fc3,R, not by the normally weak interaction between FcTR 
and Fc portions of IgG antibodies (22), but instead by the extremely high-affinity 
interaction between the 2.4G2  combining site and Fc3'R (19).  As a  result, the 
antibody with specificity for the target cell (in this paper, anti-DNP) becomes 
tightly attached to Fc'yR when low concentrations of heteroaggregates (e.g., 5 
#g/ml) are incubated with effector cell populations. Cells franked by this proce- 
dure are rendered specifically cytotoxic for the target cell (Fig. 2, Tables I and 
II).  In  addition,  the cytolysis mediated by these cells,  in  contrast to  classical 
ADCC, is not inhibited by immune complexes (Fig. 5). 
While the mouse often serves as a good experimental model for in vivo and in 
vitro  studies,  mouse cells are  notoriously poor  effectors of ADCC  especially 
against nucleated target cells (2,  3,  33).  Human K cells, a subset of peripheral 
blood  lymphocytes, and monocytes, however, are potent mediators of ADCC 
against most antibody-coated targets, including tumor cells (2, 3, 34-36). Unfor- 
tunately, a high-avidity monoclonal antibody against FcTR on human monocytes 
and  K  cells is  not  yet available.  The  3G8  antibody binds  with  relatively low 
avidity to  Fc~,R on PMN (which are less effective mediators of ADCC against 
tumor targets than are monocytes and K cells [2]) and cross-reacts with Fc~,R on 
a subset of lymphocytes (20).  While heteroaggregates containing 3G8 can pro- 
duce franked effector cells from human PMN, these cells are only weakly lytic 
against tumor targets (Table V). Moreover, high concentrations of heteroaggre- 
gates are required to successfully frank PMN. Nevertheless, the results of Table 
V demonstrate that franking can produce lytic effectors from several different 
types of cells from at least two different species. It is likely, therefore, that when 
high-avidity antibodies against human monocyte and K cell FcTR become avail- 
able, more potent human effectors against tumor targets will be produced using 
appropriate heteroaggregates, and that lysis mediated by such effectors will not 
be inhibited by monomeric IgG or immune complexes. KARPOVSKY ET AL.  1699 
Several  interesting  observations  emerge  from  these  studies  regarding  the 
mechanism of ADCC. First, the data of Fig. 3 show that ADCC can occur when 
Fc3,R are linked to the target cells through interactions different from those that 
normally occur between the ligand and receptor. However, linkage of targets to 
effectors through at  least  two  other cell surface components, the  K  d and  D d 
molecules, does not result in lysis (Fig. 6).  Therefore, conjugate formation per 
se is not sufficient for lysis.  Rather,  the data suggest that  ADCC requires, in 
addition to conjugate formation, other processes involving Fc3,R. To test whether 
the binding of antibody or ligand to FcTR could trigger lysis in nonlytic conju- 
gates, we treated such conjugates with either 2.4G2 (Table IV), soluble immune 
complexes, or  2.4G2  bound to  Sepharose beads.  In no case did treatment of 
Fc'gR  in  nonlytic conjugates lead to  lysis,  which suggests that  Fco,  R  must be 
linked directly to the target cell in order for lysis to occur. Since extensive cross- 
linking of FcTR in nonlytic conjugates (by immune complexes or 2.4G2 Sepha- 
rose) did not trigger lysis, we also conclude that either cross-linking of Fc3,R is 
not a  lytic signal or alternatively, that cross-linking of Fc3,R  does trigger lysis, 
but that it must occur locally at the region of intercellular contact. The precise 
nature of the lytic signal remains one of the most intriguing questions concerning 
the mechanism of ADCC. 
Summary 
Rabbit anti-2,4-dintrophenyl (DNP) antibodies or their F(ab')~ fragments were 
chemically cross-linked to the anti-mouse Fc'yR monoclonal antibody 2.4G2  or 
to its Fab fragment. P388D~ cells were incubated with heteroaggregates between 
2.4G2  and anti-DNP (anti-Fc3,R ×  anti-DNP) and washed. The resulting cells 
lysed 2,4,6-trinitrophenyl chicken erythrocytes (TNP CRBC) in a hapten-specific 
manner. The lysis was inhibited by free hapten but was resistant to inhibition by 
immune  complexes.  Other  cells  coated  with  antibody  heteroaggregates also 
mediated lysis of TNP-modified target cells.  For example, mouse resident peri- 
toneal  exudate  cells  (PEC)  lysed  TNP  CRBC  and  bacillus  Calmette-Gu~rin- 
activated PEC lysed both TNP CRBC and TNP tumor targets. Human neutro- 
phils, when incubated with heteroaggregates containing the anti-human neutro- 
phil FcTR antibody 3G8 and anti-DNP also lysed TNP CRBC and TNP-modified 
tumor cells.  To  test  whether linkage  to  Fc~R  was  required for lysis,  F(ab')2 
fragments from the anti-KaD  d monoclonal antibody 34-1-2 were cross-linked to 
anti-DNP F(ab')~ fragments. P388D1  cells (which express K  d and D a) were then 
incubated with these heteroaggregates and washed, and their abilities to form 
conjugates and  lyse TNP  CRBC  were compared with  those of P388D~  cells 
treated with anti-Fc3,R ×  anti-DNP.  In both cases, P388D1  cells formed conju- 
gates. However, only the cells treated with anti-Fc~,R × anti-DNP mediated lysis 
to a significant extent. We conclude that heteroaggregates containing anti-Fc3'R 
and anti-target cell antibodies can be used to create potent effector cells against 
red cell and tumor targets and that bridging of effectors with target cells directly 
to Fc3,R on effector cells is required for lysis. 
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